Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-07-12
2005-07-12
Keimmerer, Elizabeth (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S971000, C530S399000, C530S388230, C530S389100, C530S387100, C530S388100, C530S389200
Reexamination Certificate
active
06916624
ABSTRACT:
A novel member of the heregulin superfamily has been identified which is designated “γ-HRG”. This molecule, secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner. γ-HRG polypeptide and nucleic acid are disclosed, together with various uses therefor (e.g. use of γ-HRG nucleic acid for the recombinant production of γ-HRG). γ-HRG antagonists (e.g. neutralizing antibodies and antisense nucleic acid molecules) as well as uses therefor are also described.
REFERENCES:
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5183884 (1993-02-01), Kraus et al.
patent: 5367060 (1994-11-01), Vandlen et al.
patent: 444961 (1991-09-01), None
patent: 505148 (1992-09-01), None
patent: 0599274 (1994-06-01), None
patent: WO 92/18627 (1992-10-01), None
patent: WO 92/20798 (1992-11-01), None
patent: WO 93/16178 (1993-08-01), None
patent: WO 93/22424 (1993-11-01), None
patent: WO 94/00140 (1994-01-01), None
patent: WO 94/04560 (1994-03-01), None
patent: WO 94/08007 (1994-04-01), None
patent: WO 94/26298 (1994-11-01), None
patent: WO 94/28133 (1994-12-01), None
patent: WO 95/02052 (1995-01-01), None
patent: WO 95/32724 (1995-07-01), None
patent: WO 98/02541 (1998-01-01), None
Ben-Zur et al, Dev. Biol 217:107-120, (2000).
Adams et al., “Sequence identification of 2,375 human brain genes”Nature355:632-634 (Feb. 1992).
Beerli et al., “Neu Differentiation Factor Activation of ErbB-3 and ErbB-4 is Cell Specific and Displays a Differential Requirement for ErbB-2”Molecular&Cellular Biology15:6496-6505 (Dec. 1995).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”Science247:1306-1310 (1990).
Brockes et al., “Glial growth factor-like activity in Schwann Cell tumors”Annals of Neurology20:317-322 (1986).
Brockes et al., “Purification and preliminary characterization of a glial growth factor from the bovine pituitary”Journal of Biological Chemistry255(18):8374-8377 (1980).
Brockes, “Assay and isolation of glial growth factor from the bovine pituitary”Methods in Enzymology147:217-225 (1987).
Carraway and Cantley., “A Neu Acquaintance for ErbB3 and ErbB4: A Role for Receptor Heterodimerization in Growth Signaling.”Cell78:5-8 (Jul. 15, 1994).
Carraway et al., “The erbB3 gene product is a receptor for heregulin”Journal of Biological Chemistry269(19):14303-14306 (1994).
Chomczynski et al., “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction”Analytical Biochemistry162(1):156-159 (Apr. 1987).
Corfas & Fischbach, “The number of Na+channels in cultured chick muscle is increased by ARIA, an acetylcholine receptor-inducing activity”J. Neuroscience13(5):2118-2125 (1993).
Danilenko et al., “Neu differentiation factor (NDF) accelerates epidermal migration and differentiation in excisional wounds”FASEB8(4-5):abst No. 3101, p A535 (1994).
Falls et al., “ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of Neu ligand family”Cell72:801-815 (1993).
Fendly, B.M. et al., “Characterization of Murine Monclonal Antibodies Reactive to Either the Human Epidermal Growth Factor Receptor or HER2
eu Gene Product”Cancer Research50:1550-1558 (Mar. 1, 1990).
Friess et al., “Enhanced erbB-3 Expression in Human Pancreatic Cancer Correlates with Tumor Progression”Clinical Cancer Research1:1413-1420 (1995).
Gorman et al., “Transient Production of Proteins Using an Adenovirus Transformed Cell Line”DNA Prot. Eng. Tech. 2(1):3-10 (1990).
Ho, W., et al., “Sensory and Motor Neuron-derived Factor”Journal of Biological Chemistry270(24):14523-14532 (Jun. 16, 1995).
Holmes et al., “Identification of Heregulin, A Specific Activator of p185erbB2”Science256:1205-1210 (May 22, 1992).
Huang et al., “Intervening Sequences Increases Efficiency of RNA 3′ Processing and Accumulation of Cytoplasmic RNA.”Nucleic Acids Research, 18(4):937-947 (Feb. 25, 1990).
King et al., “Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2
eu proto-oncogene product is induced by hyperosmotic shock”Oncogene4(1):13-18 (Jan. 1989).
Kokai et al., “Synergistic Interaction of p185c-neu and the EGF Receptor Leads to Transformation of Rodent Fibroblasts”Cell58:287-292 (Jul. 28, 1989).
Kozak, “An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs”Nucleic Acids Research15(20):8125-8148 (Oct. 26, 1987).
Kraus et al., “Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells,”Proc. Natl. Acad. Sci. 90:2900-2904 (1993).
Kraus et al., “Isolation and Characterization of ERBB3, A Third Member of the ERBB/Epidermal Growth Factor Receptor Family: Evidence for Overexpression in a Subset of Human Mammary Tumors”Proc. Natl. Acid Sci. USA86:9193-9197 (Dec. 1989).
Kung et al., “Isolation of a heregulin-like growth factor secreted by estrogen receptor-negative MDA-MB-231 human breast cancer cells that stimulates estrogen receptor-positive cells”Biochem.&Biophys. Res. Commun. 202(3):1357-1365 (Aug. 15, 1994).
Kunkel, T., “Rapid and Efficient Site-Specific Mutagenesis Without Phenotypic Selection”Proc. Natl. Acad. Sci. 82:488-492 (1985).
LaVallie et al., “A thioredoxin gene fusion expression system that circumvents inclusion body formation in theE. colicytoplasm”Bio/Technology11(2):187-193 (Feb. 1993).
Lemke & Brockes, “Identification and purification of glial growth factor”J. Neurosci. 4(1):75-83 (1984).
Lemoine et al., “Expression of the ERBB3 gene product in breast cancer”Br. J. Cancer66:1116-1121 (1992).
Lemoine et al., “The erbB-3 gene in human pancreatic cancer”J. Pathol. 168:269-273 (1993).
Levi et al., “The functional characteristics of Schwann Cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve”J. Neuroscience14(3):1309-1319 (1994).
Lewis et al., “Differential Response of Human Tumor Cell Lines to Anti-p185HER2Monoclonal Antibodies.”Cancer Immunol. Immunother. 37:255-263 (1993).
Li et al., “Identification of Gas6 as a Growth Factor for Human Schwann Cells”The Journal of Neuroscience16(6):2012-2019 (Mar. 15, 1996).
Liu et al., “y-Heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation”Oncogene18:7110-7114 (1999).
Marchionni et al., “Glial growth factors are alternatively spliced erbB2 ligand expressed in the nervous system”Nature362:312-318 (1993).
Meyer & Birchmeier, “Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development”Proc. Natl. Acad. Sci. 91:1064-1068 (1994).
Orr-Urtreger et al., “Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21”Proc. Natl. Acad. Sci. USA90:1867-1871 (1993).
Peles et al., “Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships”EMBO Journal12(3):961-971 (1993).
Peles et al., “Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glycoprotein that Induces Differentiation of Mammary Tumor Cells”Cell69(1):205-216 (1992).
Pinkas-Kramarski et al., “Brain neurons and glial cells express Neu differentiation factor/heregulin: A survival factor for astrocytes”Proc. Natl. Acad. Sci. USA91:9387-9391 (1994).
Plowman et al., “Heregulin Induces Tyrosine Phosphorylation of HER4/p180erbB4”Nature(Letters to Nature) 366:473-475 (Dec. 2, 1993).
Plowman
Schaefer Gabriele Maria
Sliwkowski Mark
Garnett Daniel C.
Genentech Inc.
Keimmerer Elizabeth
Merchant & Gould P.C.
LandOfFree
Antibodies that bind gamma-heregulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that bind gamma-heregulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind gamma-heregulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3425352